Page results
-
There are rail strikes currently planned for Wednesday 27, Saturday 31 of July.
-
NBA Legend Isiah Thomas visited young basketball fans in the University College Hospital Macmillan Cancer Centre to chat with patients and staff, sign autographs and take selfies.
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Read more about a UCLH patient saved by special 'before midnight' transfusions.
-
Information about our UCLH Charity, charity funds and associated charities.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
File results
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2019/16 Antenatal unit questionnaire
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI2017328 Use of variable rate intravenous insulin infusion